R. C. Flanigan, S. C. Campbell, J. I. Clark, and M. M. Picken, Metastatic renal cell carcinoma, Curr Treat Options in Oncol, vol.4, pp.385-90, 2003.

F. Tas, Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors, J Oncol, 2012.

M. Yamamoto, T. Serizawa, T. Shuto, A. Akabane, Y. Higuchi et al., Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study, Lancet Oncol, vol.15, pp.387-95, 2014.

P. D. Brown, K. Jaeckle, K. V. Ballman, E. Farace, J. H. Cerhan et al., Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial, JAMA, vol.316, pp.401-410, 2016.

J. F. Fowler, The linear-quadratic formula and progress in fractionated radiotherapy, Br J Radiol, vol.62, pp.679-94, 1989.

J. Overgaard, The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study, Int J Radiat Oncol Biol Phys, vol.12, pp.867-72, 1986.

S. Ning, K. Trisler, B. W. Wessels, and S. J. Knox, Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts, Cancer, vol.80, pp.2519-2547, 1997.

E. K. Oermann, M. Kress, J. V. Todd, B. T. Collins, R. Hoffman et al., The impact of radiosurgery fractionation and tumor radiobiology on the local control of brain metastases, J Neurosurg, vol.119, pp.1131-1139, 2013.

D. Kondziolka, The biological advantage of single-session radiosurgery, J Neurosurg, vol.119, 2013.

E. A. Eisenhauer, P. Therasse, J. Bogaerts, L. H. Schwartz, D. Sargent et al., New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer Oxf Engl, vol.45, pp.228-275, 1990.

V. Grégoire and T. R. Mackie, State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy

, Cancer Radiother J Soc Francaise Radiother Oncol, vol.15, pp.555-564, 2011.

I. Paddick and B. Lippitz, A simple dose gradient measurement tool to complement the conformity index, J Neurosurg, vol.105, pp.194-201, 2006.

P. R. Rosenbaum and D. B. Rubin, The central role of the propensity score in observational studies for causal effects, Biometrika, vol.70, pp.41-55, 1983.

P. R. Rosenbaum, Model-based direct adjustment, J Am Stat Assoc, vol.82, pp.387-94, 1987.

A. Kassambara, M. Kosinski, P. Biecek, and F. S. Survminer, Drawing Survival Curves using "ggplot2, 2017.

. R-core-team, R: A language and environment for statistical computing, 2013.

S. Lwu, P. Goetz, E. Monsalves, M. Aryaee, J. Ebinu et al., Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases, Oncol Rep, vol.29, pp.407-419, 2013.

K. A. Ahmed, S. Sarangkasiri, P. Chinnaiyan, S. Sahebjam, H. Yu et al., Outcomes following Hypofractionated stereotactic radiotherapy in the Management of Brain Metastases, Am J Clin Oncol, vol.39, pp.379-83, 2016.

D. Rades, S. Huttenlocher, N. Gebauer, D. Hornung, N. T. Trang et al., Impact of stereotactic radiosurgery dose on control of cerebral metastases from renal cell carcinoma, Anticancer Res, vol.35, pp.3571-3575, 2015.

A. Yaeh, T. Nanda, J. A. Rozenblat, T. Qureshi, Y. Saad et al., Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery, J Neuro-Oncol, vol.124, pp.507-521, 2015.

J. M. Frakes, N. B. Figura, K. A. Ahmed, T. Juan, N. Patel et al., Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases, J Neurosurg, vol.123, pp.1261-1268, 2015.

C. Tuleasca, L. Negretti, M. Faouzi, V. Magaddino, T. Gevaert et al., Radiosurgery in the management of brain metastasis: a retrospective singlecenter study comparing gamma knife and LINAC treatment, J Neurosurg, vol.128, issue.2, pp.352-61, 2018.

R. Kotecha, J. A. Miller, V. A. Venur, A. M. Mohammadi, S. T. Chao et al., Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome, J Neurosurg, vol.129, pp.50-59, 2018.

G. Minniti, C. Scaringi, S. Paolini, G. Lanzetta, A. Romano et al., Single-fraction versus multifraction (3 × 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis, Int J Radiat Oncol Biol Phys, vol.95, pp.1142-1150, 2016.

J. M. Brown, D. J. Carlson, and D. J. Brenner, The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?, Int J Radiat Oncol Biol Phys, vol.88, pp.254-62, 2014.

P. W. Sperduto, C. W. Song, J. P. Kirkpatrick, and E. Glatstein, A hypothesis: indirect cell death in the radiosurgery era, Int J Radiat Oncol Biol Phys, vol.91, pp.11-14, 2015.

J. P. Kirkpatrick, J. J. Meyer, and L. B. Marks, The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery, Semin Radiat Oncol, vol.18, pp.240-243, 2008.

M. Garcia-barros, F. Paris, C. Cordon-cardo, D. Lyden, S. Rafii et al., Tumor response to radiotherapy regulated by endothelial cell apoptosis, Science, vol.300, pp.1155-1164, 2003.

M. Z. Dewan, A. E. Galloway, N. Kawashima, J. K. Dewyngaert, J. S. Babb et al., Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody, Clin Cancer Res Off J Am Assoc Cancer Res, vol.15, pp.5379-88, 2009.

S. Demaria, E. B. Golden, and S. C. Formenti, Role of local radiation therapy in Cancer immunotherapy, JAMA Oncol, vol.1, pp.1325-1357, 2015.

M. Itsumi and K. Tatsugami, Immunotherapy for renal cell carcinoma, Clin Dev Immunol, p.284581, 2010.

S. J. Gandhi, A. J. Minn, R. H. Vonderheide, E. J. Wherry, S. M. Hahn et al., Awakening the immune system with radiation: optimal dose and fractionation, Cancer Lett, vol.368, pp.185-90, 2015.

C. A. Barker and M. A. Postow, Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes, Int J Radiat Oncol Biol Phys, vol.88, pp.986-97, 2014.

Z. A. Seymour, S. E. Fogh, S. K. Westcott, S. Braunstein, D. A. Larson et al., Interval from imaging to treatment delivery in the radiation surgery age: how long is too long?, Int J Radiat Oncol Biol Phys, vol.93, pp.126-158, 2015.

M. Doré, S. Martin, G. Delpon, K. Clément, L. Campion et al., Stereotactic radiotherapy following surgery for brain metastasis: predictive factors for local control and radionecrosis, Cancer Radiother J Soc Francaise Radiother Oncol, vol.21, pp.4-9, 2017.

G. Minniti, D. 'angelillo, R. M. Scaringi, C. Trodella, L. E. Clarke et al., Fractionated stereotactic radiosurgery for patients with brain metastases, J Neuro-Oncol, vol.117, pp.295-301, 2014.

Z. A. Kohutek, Y. Yamada, T. A. Chan, C. W. Brennan, V. Tabar et al., Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases, J Neuro-Oncol, vol.125, pp.149-56, 2015.